Research-informed explainer · Last reviewed April 11, 2026
tPA vs Thrombectomy for Stroke: Which Treatment Is Better?
A plain-language comparison of the two main acute ischemic stroke treatments, grounded in the landmark trials that shaped how hospitals treat stroke today.
If you or a loved one is facing an ischemic stroke, the two main treatments you will hear about are tPA (a clot-dissolving drug) and thrombectomy (a procedure to pull the clot out). These are not either/or options. For many patients, the right answer is both, given as fast as possible.
This explainer walks through how each treatment works, who each one is for, and what the major clinical trials have shown. It draws on peer-reviewed research from four vascular neurologists listed in the Convene directory, including specialists who led or contributed to the landmark stroke trials that shape how hospitals treat stroke today.
What is tPA?
tPA stands for tissue plasminogen activator. It is a medicine given through an IV that dissolves blood clots. When an ischemic stroke happens, a clot blocks a blood vessel in the brain and cuts off oxygen to brain tissue. tPA travels through the bloodstream and breaks up the clot from the inside. It is approved for most ischemic stroke patients when it can be started within 4.5 hours of when symptoms began.
What is thrombectomy?
Thrombectomy is a procedure. A specialist threads a thin tube (a catheter) through a blood vessel in the groin or wrist up to the blocked artery in the brain. Once it reaches the clot, a device called a stent retriever grabs the clot and pulls it out. The artery reopens and blood starts flowing again. Thrombectomy is only used when the clot is in one of the larger arteries feeding the brain, which is called a large vessel occlusion.
The two treatments work differently, and for patients with a large vessel occlusion they often work best together: tPA is given first to start dissolving the clot on the way to the hospital that can do the procedure, and thrombectomy finishes the job.
At a glance
Time is brain
The phrase you will hear in any stroke center is "time is brain". A 2005 paper in the journal Stroke put real numbers behind it. A typical large vessel ischemic stroke destroys around 1.9 million neurons every minute until blood flow is restored [3]. Every hour without treatment ages the brain by roughly 3.6 years. That is why emergency medical services rush stroke patients to the closest capable hospital and why the clock on the wall of the emergency department is the single most important piece of equipment in the room.
A 2007 meta-analysis of acute stroke trials confirmed what the clock suggests. Reopening the blocked artery (which doctors call recanalization) is strongly tied to better recovery and lower death rates [4]. Any treatment that restores blood flow faster matters, and faster is almost always better.
What the landmark trials showed
For years, tPA was the only proven treatment for ischemic stroke, but it does not work for every patient. It is less effective against large clots in big arteries, and those are the strokes that cause the worst damage. Researchers kept asking whether adding a procedure could help where the drug fell short.
The IMS III trial, published in the New England Journal of Medicine in 2013, was an early attempt to answer that question. It compared IV tPA plus endovascular treatment (an older form of clot removal) to tPA alone. The trial did not find a significant difference in how well patients recovered [5]. At the time, this looked like bad news for the combined approach, but the trial was done before modern stent retrievers were widely available.
Then the technology caught up. The SWIFT PRIME trial, published in the New England Journal of Medicine in 2015, compared IV tPA alone to IV tPA plus stent-retriever thrombectomy in patients with a blocked artery in the front of the brain. Patients who got both treatments within 6 hours had clearly better function at 90 days than patients who got tPA alone [1]. That trial, along with several others published around the same time, changed stroke care. For patients with a large vessel occlusion, the standard of care became tPA plus thrombectomy, not tPA alone.
The same 2013 IMS III era also reinforced how much early treatment with tPA itself matters. An analysis in the journal Neurology found that patients who got tPA within 90 minutes of symptom onset had better odds of improvement at 24 hours and a better outcome at 3 months than those treated later in the window [6].
The extended time window
For a long time, thrombectomy was only offered within 6 hours of stroke onset. The DEFUSE 3 trial, published in the New England Journal of Medicine in 2018, changed that. It enrolled patients who were last known to be well 6 to 16 hours earlier and who still had brain tissue that was starved of oxygen but not yet dead. The trial used a special imaging scan called perfusion imaging to find those patients. Thrombectomy plus standard medical therapy produced much better recovery than medical therapy alone [2].
What this means in plain language: if you wake up with stroke symptoms or your family finds you down and nobody knows exactly when it started, you may still be a candidate for thrombectomy. The imaging is what decides eligibility, and the clock alone does not. That was a large shift in how hospitals evaluate late-arriving stroke patients, and it is why getting to a comprehensive stroke center with advanced imaging is important even when hours have passed.
The operational reality: speed matters more than the choice
Whether a patient gets tPA, thrombectomy, or both is only half the story. How fast the hospital can deliver either treatment is the other half, and hospitals vary widely.
A 2013 study in JAMA looked at more than 58,000 patients treated with IV tPA and found a clear pattern: faster treatment meant lower death rates, fewer brain bleeds, and a better chance of going home instead of to a rehab facility [7]. Every 15 minutes of delay mattered.
A 2014 follow-up in JAMA looked at what happens when hospitals actively work to speed up treatment. After a national quality improvement program focused on shortening "door-to-needle" time (the time from walking through the emergency room doors to getting the first dose of tPA), hospitals cut their median time from 77 minutes to 67 minutes. That 10-minute improvement was tied to lower in-hospital death rates, fewer bleeding complications, and more patients discharged directly home [8].
A 2019 American Heart Association statement on stroke systems of care put the same lesson into a practical framework: regions with a clear stroke triage plan, trained EMS, telestroke backup for smaller hospitals, and designated comprehensive stroke centers deliver better outcomes than regions that do not [9]. The "right" hospital is not always the closest one. For a patient who may need thrombectomy, a hospital that can do the procedure is often worth a few extra minutes of transport.
What to ask at the hospital
If you or someone you love is in the emergency department with a suspected stroke, these are fair questions to ask the team:
- Is this an ischemic stroke (from a clot) or a hemorrhagic stroke (from bleeding)? The treatments are different.
- Am I (or is my family member) a candidate for tPA? If yes, when was the last normal time, and are we still inside the window?
- Could there be a large vessel occlusion? If yes, is this hospital able to do thrombectomy, or do we need to transfer?
- If we need to transfer, how is that being coordinated, and how long will it take?
- What is the door-to-needle time here today, and how quickly can treatment begin?
You will not always get clean answers, and the team may be moving fast. That is a good sign, not a bad one.
Preventing another stroke
If you have already had a small stroke or a transient ischemic attack (TIA), the treatments above are not really the point. Your focus shifts to prevention: finding the cause of the first event and lowering the risk of a second one. That usually means working with a vascular neurologist on blood pressure control, cholesterol, blood thinners if you have atrial fibrillation, and lifestyle changes. Ask your neurologist for a specific, written prevention plan and a clear follow-up schedule.
The bottom line
tPA and thrombectomy are not competing treatments. For most ischemic stroke patients without a large vessel occlusion, tPA given as fast as possible is the treatment. For patients with a large vessel occlusion, the combination of tPA plus thrombectomy is the standard, and select patients can benefit from thrombectomy up to 16 hours after their last normal time. In every case, minutes matter.
The most important thing a patient and their family can do is recognize a stroke and call 911 immediately. The easy way to remember the warning signs is BE FAST:
- B is for balance. Sudden loss of balance or coordination.
- E is for eyes. Sudden blurred or double vision, or loss of vision in one or both eyes.
- F is for face. One side of the face droops when the person tries to smile.
- A is for arms. One arm drifts down when both are raised.
- S is for speech. Slurred, strange, or missing words.
- T is for time. Note the time symptoms started and call 911 right away.
Do not drive yourself to the hospital. Do not wait to see if symptoms get better. EMS can start the clock, pre-alert the hospital, and route the patient to the right stroke center, and every minute counts.
Research informing this article
Peer-reviewed research from the following specialists listed on Convene informs this explainer. They did not write or review the article; their published work is cited throughout.
- Gregory Albers, MD
Coyote Foundation Professor of Neurology and Neurological Sciences; Director, Stanford Stroke Center
Stanford Health Care
- Jeffrey Saver, MD
Distinguished Professor of Neurology; Director, UCLA Comprehensive Stroke and Vascular Neurology Program
Ronald Reagan UCLA Medical Center
- Joseph Broderick, MD
Professor of Neurology; Director, University of Cincinnati Gardner Neuroscience Institute
University of Cincinnati Medical Center
- Lee Schwamm, MD
Associate Dean for Digital Strategy; Professor of Neurology, Yale School of Medicine
Yale New Haven Hospital
Sources
- 1.Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke — New England Journal of Medicine, 2015. DOI
- 2.Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging — New England Journal of Medicine, 2018. DOI
- 3.
- 4.
- 5.Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke — New England Journal of Medicine, 2013. DOI
- 6.
- 7.Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke — JAMA, 2013. DOI
- 8.Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative — JAMA, 2014. DOI
- 9.
Related articles
neurology / headache medicine
Botox vs CGRP Injections for Migraines: Key Differences
Plain-language comparison of onabotulinumtoxinA (Botox) and CGRP monoclonal antibodies for chronic migraine prevention, with evidence from landmark trials.
neurology / headache medicine
CGRP Injections for Migraine: How Effective Are They Really?
A plain-language guide to CGRP monoclonal antibody injections for migraine prevention, grounded in the peer-reviewed research of leading headache specialists.
neurology / neuromuscular
Chemo-Induced Peripheral Neuropathy: Treatment Options
Evidence-based guide to chemotherapy-induced peripheral neuropathy (CIPN) — what causes it, which chemotherapy agents are highest risk, what treatment options exist, and what recovery looks like.